Crossmark

Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis

Published Online: 2021-05-17

Published Print: 2021-08

Authors

El-Rous, Magdy Abou

Saber, Sameh https://orcid.org/0000-0002-5070-7851
Raafat, Eman M.

Ahmed, Amany A. E.
License Information

Text and Data Mining valid from 2021-05-17

Version of Record valid from 2021-05-17
More Information

Article History

Received: 1 March 2021

Accepted: 4 May 2021

First Online: 17 May 2021

Declaration

:

: The authors declare no competing interests.

Document is current